Arch, a16z back Alnylam co-founder’s next big RNA play

With backing from the likes of Arch Venture Partners and Andreessen Horowitz’s health care fund, a16z Bio + Health, a new startup is planning to bundle together nearly all the RNA advances of the 21st century under one roof.